**Author Information** An event is serious (based on the ICH definition) when the patient outcome is:\* death\* life-threatening\* hospitalisation\* disability\* congenital anomaly\* other medically important event

A 61-year-old woman exhibited no improvement in acute transverse myelitis symptoms during treatment with methylprednisolone.

The woman presented with a complaint of generalised weakness on 3 April 2020. A week ago, her symptoms initially experienced chills and rhinorrhea. She was doubtful that, she had coronavirus disease 2019 (Covid-19) because she was exposed to several symptomatic coworkers potentially with Covid-19. However, she remained afebrile throughout. Three days later, she started showing symptoms of acute transverse myelitis. Initial laboratory testing revealed a positive result for Covid-19. Thereafter, on further testing of the CSF for Covid-19 showed a negative result. However, she continued to show symptoms of acute transverse myelitis. She received treatment with a five-day course of methylprednisolone \[*dosage and route not stated*\], but showed no improvement in her symptoms. Thereafter, she underwent plasmapheresis and showed a significant improvement in her symptoms. Her repeat Covid-19 tests showed negative results before the plasma exchange therapy. Unfortunately, she was still undergoing inpatient physical rehabilitation, which necessitates an intensive degree of interdisciplinary therapies.
